5J1V | Transferase | date | Mar 29, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Clk1 In Complex With Pyrido[3,4- G]Quinazoline Derivative Zw29 (Compound 13) | ||||||||||||||
authors | A.Chaikuad, Y.J.Esvan, W.Zeinyeh, T.Boibessot, L.Nauton, V.Thery, L.Meijer, F.Giraud, P.Moreau, F.Anizon, F.Von Delft, C.Bountra, C.H.Arrowsmith, A.M.Edwards, S.Knapp, Structural Genomics Cons (Sgc) | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Dual Specificity Protein Kinase Clk1 Chain: A, B, C Fragment: Unp Residues 148-484 Synonym: Cdc-Like Kinase 1 Ec: 2.7.12.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Clk1, Clk Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_variant: R3-Prare2 Expression_system_vector_type: Plasmid Expression_system_plasmid: Plic-Sgc1 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.52 Å | ||||||||||||
ligand | 6FD, GOL | enzyme | Transferase E.C.2.7.12.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure., Esvan YJ, Zeinyeh W, Boibessot T, Nauton L, Thery V, Knapp S, Chaikuad A, Loaec N, Meijer L, Anizon F, Giraud F, Moreau P, Eur J Med Chem. 2016 Apr 5;118:170-177. doi: 10.1016/j.ejmech.2016.04.004. PMID:27128181 |
Data retrieval |
View 5J1V in 3D |
Visual 3D analysis of 5J1V |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5J1V |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |